Table 4.
Clinical characteristics of 317 patients registered by European sites in the T-cell project
| Overall | Italy | United Kingdom | Others * | ||||||
| n = 317 | 57 | n = 244 | 58 | n = 46 | 57 | n = 27 | 55 | ||
| Total cases | n | % | Total cases | % | Total cases | % | Total cases | % | |
| Age (≥ 60 yrs) | 317 | 152 | 48 | 244 | 50 | 46 | 41 | 27 | 37 |
| Gender (Male) | 196 | 62 | 59 | 70 | 70 | ||||
| ECOG (>) | 247 | 51 | 21 | 190 | 20 | 34 | 12 | 23 | 35 |
| B-symptoms | 131 | 53 | 52 | 44 | 74 | ||||
| Disease-related discomfort | 184 | 74 | 74 | 71 | 87 | ||||
| Stage (III-IV) | 225 | 180 | 80 | 174 | 83 | 31 | 64 | 20 | 75 |
| Bone marrow (involvement) | 201 | 51 | 25 | 155 | 27 | 28 | 14 | 18 | 28 |
| IPI low-low/ intermediate | 214 | 123 | 57 | 169 | 54 | 31 | 77 | 14 | 57 |
| PIT low-low/intermediate | 194 | 114 | 59 | 153 | 56 | 27 | 78 | 14 | 50 |
ECOG: Eastern Cooperative Oncology Group classification; IPI: International Prognostic Index; PIT: Prognostic index of peripheral T-cell lymphomas
* Switzerland, Slovakia and Spain